Search

Search Results

• MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.

  Maria Ilaria Del Principe

  e2016052

  2016-10-20

  https://doi.org/10.4084/mjhid.2016.052

  4562

  PDF: 1284

  HTML: 1889

  Untitled: 166

  Untitled: 163

• ASSOCIATION OF MYCOBACTERIUM TUBERCULOSIS LINEAGES WITH IFN-? AND TNF-? GENE POLYMORPHISMS AMONG PULMONARY TUBERCULOSIS PATIENT

  Mohammad Varahram, Parissa Farnia, Mohammad Javad Nasiri, Mona Afraei Karahrudi, Mehdi Kazampour, Ali Akbar Velayati

  e2014015

  2014-02-16

  https://doi.org/10.4084/mjhid.2014.015

  1531

  PDF: 910

  HTML: 2210

• AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA STILL A VALID TREATMENT OPTION, OR IS THE GAME OVER ?

  Fabienne McClanahan, Peter Dreger

  e2012071

  2012-11-06

  https://doi.org/10.4084/mjhid.2012.071

  2358

  PDF: 780

  HTML: 1639

• COMPARISON OF EMPIRIC ANTIBIOTIC ESCALATION THERAPY WITH VANCOMYCIN (VAN) VERSUS LINEZOLID (LIN) IN PATIENTS WITH FEBRILE NEUTROPENIA

  Karin Mayer, Nicolaus Hegge, Ernst Molitor, Peter Brossart, Corinna Hahn-Ast

  e2022032

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.032

  927

  PDF: 509

  HTML: 191

• MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman

  Davide Matino, Paul Tieu, Dr., Antony Chan

  e2020001

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.001

  3059

  PDF: 1565

  HTML: 393

• Acquired von Willebrand Syndrome associated to secondary IgM MGUS emerging after Autologous Stem Cell Transplantation for AL Amyloidosis

  Victor H Jimenez-Zepeda, Hina Qamar, Adrienne Lee, Karen Valentine, Leslie Skeith

  e2017034

  2017-05-01

  https://doi.org/10.4084/mjhid.2017.034

  2592

  PDF: 1004

  HTML: 1152

• Sickle Cell Disease: Management options and challenges in developing countries

  Daniel Ansong, Alex Osei-Akoto, Delaena Ocloo, Kwaku Ohene-Frempong Ohene-Frempong

  e2013062

  2013-11-04

  https://doi.org/10.4084/mjhid.2013.062

  2363

  PDF: 1222

  HTML: 988

• PROPHYLAXIS OF MALARIA

  Eli Schwartz

  e2012045

  2012-06-29

  https://doi.org/10.4084/mjhid.2012.045

  2956

  PDF: 993

  HTML: 17775

  Figures SChwartz: 148

• Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case

  Sharon Lionel, Liron Barnea Slonim, Guy Hannah, Victoria Potter, Daniele Avenoso

  e2024048

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.048

  964

  PDF: 947

  HTML: 140

• A novel ALAS2 mutation causes congenital sideroblastic anemia

  Kun Yang

  e2023062

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.062

  621

  PDF: 490

  HTML: 127

• Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)

  Salam Alkindi, Dr. , Dr.

  e2021059

  2021-09-01

  https://doi.org/10.4084/MJHID.2021.059

  2008

  PDF: 456

  HTML: 117

• NEGATIVE IMPACT OF PROLONGED ANTIBIOTICS OR PERSISTENT DIARRHEA ON VITAMIN K1 LEVELS IN 2-24 WEEKS AGED EGYPTIAN INFANTS

  Mohsen Elalfy, Fatma S E Ebeid, Iman Elagouza, Fatma Ibrahim, Noura Hassan, Beshoy Botros

  e2018010

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.010

  4189

  PDF: 803

  HTML: 953

• IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

  Franco Aversa, Lucia Prezioso, Ilenia Manfra, Federica Galaverna, Angelica Spolzino, Alessandro Monti

  e2016057

  2016-10-25

  https://doi.org/10.4084/mjhid.2016.057

  4233

  PDF: 1067

  HTML: 1382

• DOES INSULIN LIKE GROWTH FACTOR-1 (IGF-1) DEFICIENCY HAVE A “PROTECTIVE” ROLE IN THE DEVELOPMENT OF DIABETIC RETINOPATHY IN THALASSEMIA MAJOR PATIENTS?

  Vincenzo De Sanctis

  e2015038

  2015-05-20

  https://doi.org/10.4084/mjhid.2015.038

  1889

  PDF: 904

  HTML: 5050

• Bacillus Cereus catheter related bloodstream infection in a patient in a patient with acute lymphblastic leukemia

  Lütfiye Öksüz, N Gurler, M Muftuoglu, FD Sargin, SK Besisik

  e2012004

  2012-01-18

  https://doi.org/10.4084/mjhid.2012.004

  1521

  PDF: 1061

  HTML: 1054

• POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

  Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles

  e2010016

  2010-06-19

  https://doi.org/10.4084/mjhid.2010.016

  1135

  PDF: 713

  HTML: 568

• Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

  Daniele Derudas

  e2025025

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.025

  1448

  PDF: 1265

  HTML: 105

• LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT

  Fabian Herrera

  e2024039

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.039

  1249

  PDF: 981

  HTML: 108

• HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation

  Anna Maria Testi

  e2022038

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.038

  1043

  PDF: 716

  HTML: 188

• INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA

  Sutatta Supatharawanich, Nattee Narkbunnam, Nassawee Vathana, Chayamon Takpradit, Kamon Phuakpet, Bunchoo Pongtanakul, Sasima Tongsai, Phakatip Sinlapamongkolkul, Popchai Ngamskulrungroj, Wanatpreeya Phongsamart, Kleebsabai Sanpakit , Jassada Buaboonnam

  e2021039

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.039

  2567

  PDF: 736

  HTML: 196

• THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  Davide Rossi, Marco Fangazio, Gianluca Gaidano

  e2012076

  2012-11-13

  https://doi.org/10.4084/mjhid.2012.076

  2185

  PDF: 854

  HTML: 1982

  Fig 1 Rossi: 155

• SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY

  Ivan GUR, Roei Tounek, Yaniv Dotan, Elite Vainer Evgrafov, Stav Rakedzon, Eyal Fuchs

  e2024006

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.006

  1068

  PDF: 1262

  HTML: 161

• EXPRESSION AND CLINICAL CORRELATION OF PD-1/PD-L1 AND VE1(BRAFP.V600E) IN PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS

  sneha tandon, Sheila Weitzman , Brooklyn Joyce, Bryan Maguire, Derek Stephens, James Whitlock, Cynthia Hawkins , Bo-Yee Ngan, Oussama Abla

  e2023035

  2023-04-27

  https://doi.org/10.4084/MJHID.2023.035

  974

  PDF: 858

  HTML: 226

• Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia

  Francesco Marchesi, Fabrizio Ensoli, Irene Terrenato, Elena Papa, Fulvia Pimpinelli, Grazia Prignano, Antonio Spadea, Ilaria Cavallo, Enea Gino Di Domenico, Luigi Toma, Andrea Mengarelli

  e2020065

  2020-09-07

  https://doi.org/10.4084/mjhid.2020.065

  7758

  PDF: 696

  HTML: 195

• INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB

  Wonhee So, Shuchi Pandya, Rod Quilitz, John Greene

  e2018029

  2018-05-01

  https://doi.org/10.4084/mjhid.2018.029

  2717

  PDF: 996

  HTML: 290

• PREDICTORS OF MORTALITY IN MECHANICALLY VENTILATED CRITICAL PERTUSSIS IN A LOW INCOME COUNTRY: NEW RESURGENCE IN 2013.

  Aida Borgi

  e2014059

  2014-09-01

  https://doi.org/10.4084/mjhid.2014.059

  1193

  PDF: 737

  HTML: 1533

• THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA

  adel abd elhaleim hagag

  e2013065

  2013-11-04

  https://doi.org/10.4084/mjhid.2013.065

  2501

  PDF: 803

  HTML: 14928

  Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 273

• Bone marrow involvement in a patient with alpha heavy chain disease:Response to tetracycline treatment

  Zahit Bolaman, Irfan Yavasoglu, Gokhan Sargin, Gurhan Kadikoylu, Firuzan Kacar Doger

  e2012034

  2012-05-07

  https://doi.org/10.4084/mjhid.2012.034

  1159

  PDF: 994

  HTML: 3384

• Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report

  Martina Di Palma, Elio Gentilini, Chiara Masucci, Alessandra Micozzi, Ombretta Turriziani, Antonino Mulè, Robin Foà, Maurizio Martelli, Gabriella D'Ettorre, Saveria Capria, Sabina Chiaretti

  e2022043

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.043

  1263

  PDF: 540

  HTML: 204

• FOETAL HAEMOGLOBIN AND DISEASE SEVERITY IN NIGERIAN CHILDREN WITH SICKLE CELL ANAEMIA.

  Oluwagbemiga Adeodu, Morenike Akinlosotu, Samuel Adegoke, Saheed Oseni

  e2017063

  2017-11-01

  https://doi.org/10.4084/mjhid.2017.063

  5484

  PDF: 1002

  HTML: 940

• LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.

  Andrea Riccardo Filippi

  e2016041

  2016-09-01

  https://doi.org/10.4084/mjhid.2016.041

  3642

  PDF: 1055

  HTML: 2261

  Figure 1: 194

• IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?

  Fahad Al-Eidan

  e2015029

  2015-04-19

  https://doi.org/10.4084/mjhid.2015.029

  1591

  PDF: 793

  HTML: 1454

• TUBERCULOSIS IN CHILDREN

  Susanna Esposito

  e2013064

  2013-11-04

  https://doi.org/10.4084/mjhid.2013.064

  3031

  PDF: 1277

  HTML: 4806

• NOVEL RUNX1 VARIATION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

  Egzona Qipa, Muradiye Acar, Sureyya Bozkurt, Murat Buyukdogan, Hazal Berivan Sonmez, Muge Sayitoglu, Yucel Erbilgin, Zeynep Karakas, Veysel Sabri Hancer

  e2023036

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.036

  793

  PDF: 672

  HTML: 254

• A POPULATION-BASED STUDY ON MYELODYSPLASTIC SYNDROMES IN THE LAZIO REGION (ITALY), MEDICAL MISCODING AND 11-YEAR MORTALITY FOLLOW-UP: THE GRUPPO ROMANO-LAZIALE MIELODISPLASIE EXPERIENCE OF RETROSPECTIVE MULTICENTRIC REGISTRY

  Flavia Mayer, Laura Faglioni, Nera Agabiti, Susanna Fenu, Francesco Buccisano, Roberto Latagliata, Roberto Ricci, Maria Antonietta Aloe Spiriti, Caterina Tatarelli, Massimo Breccia, Giuseppe Cimino, Luana Fianchi, Svitlana Gumenyuk, Stefano Mancini, Luca Maurillo, Carolina Nobile, Pasquale Niscola, Anna Lina Piccioni, Agostino Tafuri, Giulio Trapè, Alessandro Andriani, Paolo De Fabritis, Maria Teresa Voso, Marina Davoli, Gina Zini

  e2017046

  2017-07-01

  https://doi.org/10.4084/mjhid.2017.046

  2556

  PDF: 963

  HTML: 1095

• Complete Remission Obtained with Azacitidine in a Patient with Concomitant Therapy Related Myeloid Neoplasm and Pulmonary Mucormycosis

  Saveria Capria, Federico De Angelis, Giuseppe Gentile, Silvia Maria Trisolini, Simonetta Brocchieri, Martina Canichella, Patrizia Chiusolo, Alessandra Micozzi, Robin Foà, Giovanna Meloni

  e2013048

  2013-07-10

  https://doi.org/10.4084/mjhid.2013.048

  1470

  PDF: 650

  HTML: 1876

• Penile ulcer ATRA related in patient with acute promyelocytic leukemia

  Irfan Yavasoglu, Mustafa Unubol, Gokhan Sargin, Gurhan Kadikoylu, Zahit Bolaman

  e2012054

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.054

  1041

  PDF: 657

  HTML: 463

• CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2022069

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.069

  1878

  PDF: 836

  HTML: 1266

• Concurrent diagnosis of acute myeloid leukemia and symptomatic COVID-19 infection: a case report successfully treated with Azacitidine-Venetoclax combination

  Daniela Taurino, Marco Frigeni, Anna Grassi, Gianluca Cavallaro, Silvia Salmoiraghi, Orietta Spinelli, Alessandro Rambaldi, Federico Lussana

  e2021057

  2021-08-28

  https://doi.org/10.4084/MJHID.2021.057

  1110

  PDF: 461

  HTML: 156

• PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome

  Kalman Filanovsky, Michal Haran, Vita Mirkin, Andrei Braester, Olga Shevetz, Anfisa Stanevsky, Erica Sigler, Ekaterina Votinov, Yehudit Zalzman-Amir, Alain Berrebi, Atan Gross, Lev Shvidel

  e2020072

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.072

  1014

  PDF: 741

  HTML: 271

• DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.

  Maria Concetta Postorino, Filippo Luciani, Carmelo Mangano, Maria Stella Carpentieri, Paolo Scerbo, Armando Priamo, Giuseppina Berardelli, Roberto Marino, Alfredo Vallone, Nicola Serrao, Vincenzo Pisani, Chiara Costa, Albano Terremoto, Giuseppe Foti, Lucio Cosco, Massimo Calderazzo, Domenico Corigliano, Preziosa Scordo, Carlo Torti, Alessio Strazzulla

  e2015054

  2015-10-08

  https://doi.org/10.4084/mjhid.2015.054

  1555

  PDF: 767

  HTML: 1219

  Figure 1: 152

  Figure 2: 168

  Figure 3: 165

• PREDISPOSING FACTORS TO INFECTIONS IN THALASSEMIA SYNDROME PATIENTS

  Eman M Mansory, Lina M. Abdulrahman, Balsam Osman, Sawsan M. Sawsan, Assil F. Ruckn, Marwa Aljedaani, Nemmat Hassan, Ahmed S. Barefah, Hatem M. Alahwal, Yassir Daghistani, Salem M. Bahashwan, Abdullah T. Almohammadi, Osman O. Radhwi

  e2025055

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.055

  1364

  PDF: 991

  HTML: 306

• DIAGNOSIS AND PROGNOSIS EVALUATION OF SEVERE PNEUMONIA BY LUNG ULTRASOUND SCORE COMBINED WITH SERUM INFLAMMATORY MARKERS.

  Bo Fu, Peng Zhang, JunHua Zhang

  e2023057

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.057

  724

  PDF: 532

  HTML: 114

• CIRCCTNNA1 IS UPREGULATED IN MANTLE CELL LYMPHOMA AND PREDICTS POOR SURVIVAL BY SPONGING MIR-34A TO INCREASE CELL PROLIFERATION.

  Xuebing Jing, Cong Lu, Chao Song, Qingkun Han

  e2022047

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.047

  586

  PDF: 469

  HTML: 201

• THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies

  Emine Atli, Rasime Kalkan, Cisem Mail, Damla Eker, Ufuk Demirci, Selma Demir, Sinem Yalcintepe, Hakki Onur Kirkizlar, Engin Atli, Hakan Gurkan, Ahmet Muzaffer Demir

  e2021013

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.013

  1432

  PDF: 500

  HTML: 242

• THE EVOLVING PHARMACOTHERAPEUTIC LANDSCAPE FOR THE TREATMENT OF SICKLE CELL DISEASE

  Samir Ballas

  e2020010

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.010

  3059

  PDF: 2913

  HTML: 1094

• MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS

  Elena Maino, Anna Maria Scattolin, Piera Viero, Rosaria Sancetta, Anna Pascarella, Michele Vespignani, Renato Bassan

  e2015001

  2015-01-01

  https://doi.org/10.4084/mjhid.2015.001

  2211

  PDF: 1296

  HTML: 17058

  Bassan Fig.1: 133

  Bassan Fig.2: 131

  Bassan Fig.4: 126

  Fig.3: 164

• SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs

  Massimo Breccia, Giuliana Alimena

  e2014003

  2014-01-02

  https://doi.org/10.4084/mjhid.2014.003

  3035

  PDF: 1172

  HTML: 3454

• BEHÇET’S SYNDROME AND THROMBOSIS

  Emire Seyahi, Sebahattin Yurdakul

  e2011026

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.026

  2770

  PDF: 1611

  HTML: 16950

• VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES

  Sanaa M. Kamal, Sara Mahmoud, Tamer Hafez, Runia EL Fouly

  e2010001

  2010-02-09

  https://doi.org/10.4084/mjhid.2010.001

  1203

  PDF: 632

  HTML: 7708